- ￥4675
- OriGene
- 美国
- AM31855BT-N
- 2026年04月01日
- ELISA, R, WB
- Mouse
- Human
企业认证
相关产品推荐更多 >
Rabbit polyclonal antibody to NQO1 (NAD(P)H dehydrogenase, quinone 1)
￥6281
Anti-CCL2(carlumab biosimilar) mAb, Biotinylated
￥2580
VCAM1 mouse monoclonal antibody, clone OTI3H10 (formerly 3H10)
￥1999Nuclear Antigen (Nuclei + Chromosomes) mouse monoclonal antibody, clone 1415-1 (21NC85), Purified
￥8520
RLBP1 (CRALBP) mouse monoclonal antibody, clone OTI1G6 (formerly 1G6), HRP conjugated
￥3990
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Human IgG Fd
- 形态：
PBS containing 0.02% Sodium Azide as preservative and EIAgrade BSA as a stabilizing protein to bring total protein concentration to 4-5 mg/ml.Label: BiotinState: Liquid purified IgG fraction.
- 保存条件：
Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.Avoid repeated freezing and thawing.
- 克隆性：
Monoclonal
- 适应物种：
Human
- 保质期：
Stable for 12 months from date of receipt.
- 目录编号：
AM31855BT-N
- 级别：
科研级
- 库存：
5周
- 供应商：
OriGene
- 宿主：
Mouse
- 应用范围：
ELISA, R, WB
- 抗体英文名：
Human IgG (Fd region) mouse monoclonal antibody, clone HP6045, Biotin
- 抗体名：
Human IgG (Fd region) mouse monoclonal antibody, clone HP6045, Biotin
- 规格：
100 ug
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
Production of a Human Antibody Library in the Phage-Display Vector pSEX81
(1 ,2 ). A promising alternative 1s the production of human recombinant antibodies (3 ). Recombinant DNA technology has made it possible to clone human antibody genes in vectors and to generate antibody expression libraries (4–7). One approach has been to amplify
Generation of Antibody Molecules Through Antibody Engineering
been overcome to a large extent using genetic-engineering techniques to produce chimeric mouse/human and completely human antibodies. Such an approach is particularly suitable because of the domain structure of the antibody molecule ( 2 ), where functional
技术资料暂无技术资料 索取技术资料
